Express Scripts Holding Co. (NASDAQ:ESRX) shares saw strong trading volume on Monday . 3,076,430 shares were traded during trading, a decline of 17% from the previous session’s volume of 3,705,649 shares.The stock last traded at $73.58 and had previously closed at $72.31.

Several equities research analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Tuesday, July 19th. Barclays PLC increased their target price on shares of Express Scripts Holding from $85.00 to $87.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 27th. Jefferies Group decreased their target price on shares of Express Scripts Holding from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Tuesday, July 26th. Mizuho increased their target price on shares of Express Scripts Holding from $77.00 to $82.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 2nd. Finally, Bank of America Corp. reiterated a “neutral” rating and set a $82.00 target price on shares of Express Scripts Holding in a research note on Tuesday, June 7th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $81.26.

The stock has a 50 day moving average price of $76.84 and a 200 day moving average price of $73.49. The stock has a market cap of $46.08 billion and a PE ratio of 18.07.

Express Scripts Holding (NASDAQ:ESRX) last released its earnings results on Monday, July 25th. The company reported $1.57 EPS for the quarter, hitting analysts’ consensus estimates of $1.57. The business earned $25.20 billion during the quarter, compared to the consensus estimate of $25.42 billion. The firm’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.44 earnings per share. Equities research analysts forecast that Express Scripts Holding Co. will post $6.38 EPS for the current year.

Several hedge funds have added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. increased its stake in Express Scripts Holding by 12.2% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 2,270,630 shares of the company’s stock worth $198,476,000 after buying an additional 246,358 shares during the last quarter. Wafra Investment Advisory Group Inc. NY raised its stake in Express Scripts Holding by 975.2% in the fourth quarter. Wafra Investment Advisory Group Inc. NY now owns 165,049 shares of the company’s stock worth $14,427,000 after buying an additional 149,699 shares in the last quarter. KBC Group NV raised its stake in Express Scripts Holding by 128.2% in the fourth quarter. KBC Group NV now owns 207,262 shares of the company’s stock worth $18,116,000 after buying an additional 116,434 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in Express Scripts Holding by 95.7% in the fourth quarter. BNP Paribas Arbitrage SA now owns 139,807 shares of the company’s stock worth $12,221,000 after buying an additional 68,376 shares in the last quarter. Finally, Airain ltd purchased a new stake in Express Scripts Holding during the fourth quarter worth about $4,009,000.

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.